Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase [Phase 1]

View source ↗

Summary

Pfizer terminated a Phase 1 pharmacokinetic and pharmacodynamic study of bococizumab, both alone and with recombinant human hyaluronidase, in healthy volunteers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Bococizumab (bococizumab)
• Recombinant human hyaluronidase (recombinant human hyaluronidase (rHuPH20))

Snippet

Sponsor: Pfizer | Conditions: Healthy, Hypercholesterolemia | Phase 1 | Status: TERMINATED